JANX - Janux Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts4455
Avg. Estimate-0.52-0.54-1.99-2.48
Low Estimate-0.61-0.67-2.41-2.86
High Estimate-0.43-0.43-1.73-2.01
Year Ago EPS-0.41-0.4-1.52-1.99
Revenue EstimateCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
No. of Analysts4444
Avg. Estimate870k870k4.53M2.21M
Low EstimateN/AN/A2MN/A
High Estimate1.5M1.5M6.04M5M
Year Ago Sales2.37M740k8.61M4.53M
Sales Growth (year/est)-63.20%17.60%-47.40%-51.20%
Earnings History2022-06-292022-09-292022-12-302023-03-30
EPS Est.-0.37-0.49-0.49-0.49
EPS Actual-0.41-0.4-0.39-0.42
Difference-0.040.090.10.07
Surprise %-10.80%18.40%20.40%14.30%
EPS TrendCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Current Estimate-0.52-0.54-1.99-2.48
7 Days Ago-0.52-0.54-1.99-2.48
30 Days Ago-0.52-0.54-2.23-2.45
60 Days Ago-0.5-0.5-2.19-2.34
90 Days Ago-0.48-0.47-2.16-2.21
EPS RevisionsCurrent Qtr. (Jun 2023)Next Qtr. (Sep 2023)Current Year (2023)Next Year (2024)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days3152
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesJANXIndustrySector(s)S&P 500
Current Qtr.-26.80%N/AN/AN/A
Next Qtr.-35.00%N/AN/AN/A
Current Year-30.90%N/AN/AN/A
Next Year-24.60%N/AN/AN/A
Next 5 Years (per annum)8.70%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A